Tuberculosis outbreak in East Greenland: groups at risk in an isolated arctic setting.

References 1 Nixon GM, Armstrong DS, Carzino R, et al. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr 2001; 138: 699–704. 2 Emerson J, Rosenfeld M, McNamara S, et al. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol 2002; 34: 91–100. 3 Frederiksen B, Koch C, Hoiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol 1997; 23: 330–335. 4 UK Cystic Fibrosis Registry. Annual Data Report 2012. Kent, Cystic Fibrosis Trust, 2013. 5 De Boeck K, Wilschanski M, Castellani C, et al. Cystic fibrosis: terminology and diagnostic algorithms. Thorax 2006; 61: 627–635. 6 Kenny SL, Shaw TD, Downey DG, et al. Eradication of Pseudomonas aeruginosa in adults with cystic fibrosis. BMJ Open Respir Res 2014; 1: e000021. 7 Kappler M, Kraxner A, Reinhardt D, et al. Diagnostic and prognostic value of serum antibodies against Pseudomonas aeruginosa in cystic fibrosis. Thorax 2006; 61: 684–688. 8 Taccetti G, Campana S, Festini F, et al. Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients. Eur Respir J 2005; 26: 458–461. 9 Schelstraete P, Deschaght P, Van Simaey L, et al. Genotype based evaluation of Pseudomonas aeruginosa eradication treatment success in cystic fibrosis patients. J Cyst Fibros 2010; 9: 99–103. 10 Hansen CR, Pressler T, Hoiby N. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience. J Cyst Fibros 2008; 7: 523–530.